Entry of New Manufacturers and Adoption of Automation Solutions to Augment Growth of Travel Mobility Scooter Market

 

Travel Mobility Scooter Market

Entry of new manufacturers and adoption of automation solutions is expected to propel growth of the global travel mobility scooter market. For instance, in February 2021, Ola selected ABB as one of its key partners for robotics and automation solutions for its electric scooter factory in India. Moreover, launch of new products is also expected to aid in growth of the market. For instance, in February 2021, TVS launched TVS iQube electric scooter for on-road price of US$ 1,487.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global travel mobility scooter market. The pandemic has changed attitudes to transport and walking, which has prompted several start-ups to launch e-scooters. For instance, in November 2020, the U.S.-based startup Lime launched a new e-scooter model. Moreover, initiatives to curb air pollution are also expected to aid in growth of the market. For instance, in February 2021, The New Delhi Municipal Council, India, announced to re-invite bids for its electric scooter project.

The global travel mobility scooter market is witnessing entry of new manufacturers. For instance, in February 2021, Xiaomi, the smartphone manufacturer, launched the Mi Electric Scooter Pro 2 Mercedes-AMG Petronas F1 Team Edition.  Moreover, decreasing deposits of fossil fuel worldwide are expected to propel growth of the market. Fossil deposits are limited in nature. However, the use of oil, a major fossil fuel, is significantly increasing. For instance, according to the International Energy Agency, the U.S. alone will cover 80% of the world’s oil demand from 2018 to 2020.

Among regions, Asia Pacific is expected to witness significant growth in the travel mobility scooter market, owing to launch of new products. For instance, in February 2021, Neuron Mobility, launched a 250-strong fleet of purpose-built e-scooters in Dunedin, New Zealand

Competitive Analysis

Major players operating in the global travel mobility scooter market include, Merits Health Products, Pride Mobility Products, Afikim Electric Vehicles, Invacare, TVS, Sunrise Medical, Roma Medical, Drive Medical, Golden Technologies, Hoveround Corp, Detel, Quingo, TGA Mobility, Electric Mobility, Van Os Medical, Kymco, Amigo Mobility, Neuron Mobility Pte. Ltd., and Vermeiren.

Major players operating in the global travel mobility scooter market are focused on launching new products to expand their product portfolio. For instance, in February 2021, Detel launched Detel Easy Plus, an electric two-wheeler, at India Auto Show 2021.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more